Recombinant MAPT (Tilavonemab Biosimilar) antibody

Catalog No. ABIN7666386

The Human Monoclonal anti-MAPT (Tilavonemab Biosimilar) antibody has been validated for . It is suitable to detect MAPT (Tilavonemab Biosimilar) in samples from Human.

Quick Overview for Recombinant MAPT (Tilavonemab Biosimilar) antibody (ABIN7666386)

Target: MAPT (Tilavonemab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This MAPT (Tilavonemab Biosimilar) antibody is un-conjugated

Application: Please inquire

Product Details anti-MAPT (Tilavonemab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Tau antibody (Tilavonemab biosimilar)

Purity: ≥95 % (SDS-PAGE&SEC)

Isotype: IgG1

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Storage Comment: Please store the product under the recommended conditions in the the instructions.

Target Details for MAPT (Tilavonemab Biosimilar)

Target: MAPT (Tilavonemab Biosimilar)

Alternative Name: Tilavonemab biosimilar

Target Type: Biosimilar

Background: Tilavonemab | MAPT

Gene ID: 4137

UniProt: P10636